| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4044794
[patent_doc_number] => 05869262
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-09
[patent_title] => 'Method for monitoring an inflammatory disease state by detecting circulating ICAM-R'
[patent_app_type] => 1
[patent_app_number] => 8/473503
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 39
[patent_no_of_words] => 54938
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/869/05869262.pdf
[firstpage_image] =>[orig_patent_app_number] => 473503
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/473503 | Method for monitoring an inflammatory disease state by detecting circulating ICAM-R | Jun 6, 1995 | Issued |
Array
(
[id] => 4105597
[patent_doc_number] => 06100383
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-08
[patent_title] => 'Fusion proteins comprising ICAM-R polypeptides and immunoglobulin constant regions'
[patent_app_type] => 1
[patent_app_number] => 8/475680
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 39
[patent_no_of_words] => 57799
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/100/06100383.pdf
[firstpage_image] =>[orig_patent_app_number] => 475680
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/475680 | Fusion proteins comprising ICAM-R polypeptides and immunoglobulin constant regions | Jun 6, 1995 | Issued |
| 08/478326 | ANTI-AMYLOID PEPTIDES IN THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSIS DISORDERS | Jun 6, 1995 | Abandoned |
Array
(
[id] => 3933444
[patent_doc_number] => 05972659
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-26
[patent_title] => 'Multispecific antigenic proteins'
[patent_app_type] => 1
[patent_app_number] => 8/472178
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 18
[patent_no_of_words] => 5694
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/972/05972659.pdf
[firstpage_image] =>[orig_patent_app_number] => 472178
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/472178 | Multispecific antigenic proteins | Jun 6, 1995 | Issued |
Array
(
[id] => 3767504
[patent_doc_number] => 05773293
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-30
[patent_title] => 'Anti-ICAM-4 antibodies and hybridomas'
[patent_app_type] => 1
[patent_app_number] => 8/485604
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15671
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/773/05773293.pdf
[firstpage_image] =>[orig_patent_app_number] => 485604
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/485604 | Anti-ICAM-4 antibodies and hybridomas | Jun 6, 1995 | Issued |
Array
(
[id] => 4146920
[patent_doc_number] => 06063755
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-16
[patent_title] => 'Intestinal trefoil proteins'
[patent_app_type] => 1
[patent_app_number] => 8/476705
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6421
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/063/06063755.pdf
[firstpage_image] =>[orig_patent_app_number] => 476705
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/476705 | Intestinal trefoil proteins | Jun 6, 1995 | Issued |
Array
(
[id] => 1533416
[patent_doc_number] => 06410598
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-25
[patent_title] => 'Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis'
[patent_app_type] => B1
[patent_app_number] => 08/477364
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 19613
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/410/06410598.pdf
[firstpage_image] =>[orig_patent_app_number] => 08477364
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/477364 | Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis | Jun 6, 1995 | Issued |
Array
(
[id] => 3998444
[patent_doc_number] => 06004563
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-21
[patent_title] => 'Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same'
[patent_app_type] => 1
[patent_app_number] => 8/467775
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7367
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/004/06004563.pdf
[firstpage_image] =>[orig_patent_app_number] => 467775
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/467775 | Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same | Jun 5, 1995 | Issued |
Array
(
[id] => 797806
[patent_doc_number] => 07427392
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-09-23
[patent_title] => 'Methods for aiding in the diagnosis of alzheimer\'s disease by measuring amyloid-β peptide (x-≧41) and tau'
[patent_app_type] => utility
[patent_app_number] => 08/466554
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 13790
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/427/07427392.pdf
[firstpage_image] =>[orig_patent_app_number] => 08466554
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/466554 | Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau | Jun 5, 1995 | Issued |
| 08/469492 | BYSTANDER SUPPRESSION OF AUTOIMMUNE DISEASES | Jun 5, 1995 | Abandoned |
Array
(
[id] => 1275713
[patent_doc_number] => 06645504
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-11
[patent_title] => 'Bystander suppression of type I diabetes by oral administration of glucagon'
[patent_app_type] => B1
[patent_app_number] => 08/468996
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 19287
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/645/06645504.pdf
[firstpage_image] =>[orig_patent_app_number] => 08468996
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/468996 | Bystander suppression of type I diabetes by oral administration of glucagon | Jun 5, 1995 | Issued |
Array
(
[id] => 4156178
[patent_doc_number] => 06124438
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-26
[patent_title] => 'Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mRNAs, receptors, methods and diagnostics using the same'
[patent_app_type] => 1
[patent_app_number] => 8/466927
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 39
[patent_no_of_words] => 19907
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/124/06124438.pdf
[firstpage_image] =>[orig_patent_app_number] => 466927
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/466927 | Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mRNAs, receptors, methods and diagnostics using the same | Jun 5, 1995 | Issued |
| 08/472017 | BYSTANDER SUPPRESSION OF AUTOIMMUNE DISEASES | Jun 5, 1995 | Abandoned |
Array
(
[id] => 4115532
[patent_doc_number] => 06071705
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-06
[patent_title] => 'Method of detecting neurological disease or dysfunction'
[patent_app_type] => 1
[patent_app_number] => 8/469629
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 26
[patent_no_of_words] => 17792
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/071/06071705.pdf
[firstpage_image] =>[orig_patent_app_number] => 469629
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/469629 | Method of detecting neurological disease or dysfunction | Jun 5, 1995 | Issued |
Array
(
[id] => 4013778
[patent_doc_number] => 05880096
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-09
[patent_title] => 'Peptides and compounds that bind to the IL-1 receptor'
[patent_app_type] => 1
[patent_app_number] => 8/463076
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38975
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/880/05880096.pdf
[firstpage_image] =>[orig_patent_app_number] => 463076
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/463076 | Peptides and compounds that bind to the IL-1 receptor | Jun 4, 1995 | Issued |
Array
(
[id] => 4201324
[patent_doc_number] => 06077517
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-20
[patent_title] => 'House dust mite allergen, Der p VII, and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/462778
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11510
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/077/06077517.pdf
[firstpage_image] =>[orig_patent_app_number] => 462778
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/462778 | House dust mite allergen, Der p VII, and uses thereof | Jun 4, 1995 | Issued |
Array
(
[id] => 3728867
[patent_doc_number] => 05693478
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-02
[patent_title] => 'Method of detecting amyloid precursor proteins'
[patent_app_type] => 1
[patent_app_number] => 8/464247
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 54
[patent_no_of_words] => 14632
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/693/05693478.pdf
[firstpage_image] =>[orig_patent_app_number] => 464247
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/464247 | Method of detecting amyloid precursor proteins | Jun 4, 1995 | Issued |
Array
(
[id] => 4100212
[patent_doc_number] => 06100046
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-08
[patent_title] => 'Methods of identifying modulators of alpha9, a novel acetylcholine-gated ion channel receptor subunit'
[patent_app_type] => 1
[patent_app_number] => 8/471961
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 23
[patent_no_of_words] => 17853
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/100/06100046.pdf
[firstpage_image] =>[orig_patent_app_number] => 471961
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/471961 | Methods of identifying modulators of alpha9, a novel acetylcholine-gated ion channel receptor subunit | Jun 4, 1995 | Issued |
Array
(
[id] => 1456837
[patent_doc_number] => 06425769
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-30
[patent_title] => 'Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 08/457097
[patent_app_country] => US
[patent_app_date] => 1995-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 29325
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/425/06425769.pdf
[firstpage_image] =>[orig_patent_app_number] => 08457097
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/457097 | Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof | May 31, 1995 | Issued |
Array
(
[id] => 3998366
[patent_doc_number] => 05858687
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-12
[patent_title] => 'Cell bioassay of neurotoxins'
[patent_app_type] => 1
[patent_app_number] => 8/450877
[patent_app_country] => US
[patent_app_date] => 1995-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 25
[patent_no_of_words] => 9508
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/858/05858687.pdf
[firstpage_image] =>[orig_patent_app_number] => 450877
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/450877 | Cell bioassay of neurotoxins | May 25, 1995 | Issued |